✦ LIBER ✦

The oral direct thrombin inhibitor, ximelagatran, an alternative for anticoagulant treatment during the puerperium and lactation

✍ Scribed by M. Hellgren; S. Johansson; U.G. Eriksson; K. Wåhlander

Book ID: 111161000
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 103 KB
Volume: 112
Category: Article
ISSN: 1470-0328
DOI: 10.1111/j.1471-0528.2004.00494.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bleeding profiles of anticoagulants, inc

Bleeding profiles of anticoagulants, including the novel oral direct thrombin inhibitor ximelagatran: definitions, incidence and management

✍ David Bergqvist 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Influence of Age on the Pharmacokinetics

Influence of Age on the Pharmacokinetics and Pharmacodynamics of Ximelagatran, an Oral Direct Thrombin Inhibitor

✍ Linda C. Johansson, Lars Frison, Ulrika Logren, Gunnar Fager, David Gustafsson, 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 157 KB

Anticoagulant action of melagatran, the

Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examination

✍ Martin Koestenberger; Siegfried Gallistl; Gerhard Cvirn; Katrin Baier; Bettina L 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Long-term treatment with ximelagatran, a

Long-term treatment with ximelagatran, an oral direct thrombin inhibitor, persistently reduces the coagulation activity after a myocardial infarction

✍ C. CHRISTERSSON; J. OLDGREN; A. BYLOCK; L. WALLENTIN; A. SIEGBAHN 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB

No Influence of Mild-To-Moderate Hepatic

No Influence of Mild-To-Moderate Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Ximelagatran, an Oral Direct Thrombin Inhibitor

✍ Dr Karin Wåhlander, Maria Eriksson-Lepkowska, Lars Frison… 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 131 KB

Pharmacokinetics, pharmacodynamics and c

Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis

✍ Karin Wåhlander; Leif Lapidus; Carl-Gustav Olsson; Anneli Thuresson; Ulf G Eriks 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 165 KB